Montagu Private Equity completed the acquisition of the sports and reconstructive surgery implants division of RTI Surgical, a medical technology company for $490m. The transaction is subject to approval from RTI Surgical Holdings’ shareholders, customary regulatory approvals and the satisfaction of customary closing conditions and is targeted to close in the first half of 2020. “RTI’s OEM business is an excellent fit for Montagu’s investment strategy. We look forward to working with Olivier and the team to support the business in this exciting next chapter of growth, maintaining its ethos of exceptional service and innovation,” Guillaume Jabalot, Montagu Director.